greeksoup/ stock research

Enerpac Tool Group Corp.: Q1 FY2026 earnings call

What management said about Q1 FY2026, from the documents filed with the SEC on 17 December 2025: press release. Guidance figures: 10 kept. The quarter’s numbers.

Key takeaways

  • Net sales slightly lower: Net sales were $144.2 million, down 1% from $145.2 million a year earlier. Organic sales declined 2% year over year. Source
  • Adjusted EBITDA declined to $32.4 million: Adjusted EBITDA was $32.4 million against $34.3 million in the prior-year quarter. Source
  • Product sales up, service sales down: Within IT&S, product sales rose 4% on an organic basis, while service revenue fell 26% year over year. Source
  • Order growth described as stronger: Management described order growth as even stronger than the solid sales growth it cited, and tied it to its posture entering 2026. Source
  • Adjusted EBITDA margin down 120 basis points: Adjusted EBITDA margin was 22.4%, from 23.6% in the prior-year quarter, on lower gross margin and slight operating expense deleveraging. Source
  • Operating cash generation improved: Cash provided by operating activities was $16.0 million, compared with $8.6 million in the prior-year period. Source
  • Share repurchases returned about $15 million: The company bought about 377,000 shares for $14.9 million in the quarter. Source

“Our first quarter results were essentially as expected,”

Paul Sternlieb, Enerpac Tool Group's President & CEO

Guidance

AreaPeriodFigureAgainst last quarter
Net sales Sourcefiscal 2026$635 million to $655 millionKept
Organic sales growth Sourcefiscal 20261% to 4%Kept
Adjusted EBITDA Sourcefiscal 2026$158 million to $168 millionKept
Adjusted EPS Sourcefiscal 2026$1.85 to $2.00Kept
Free cash flow Sourcefiscal 2026$100 million to $110 millionKept
Cash provided by operating activities Sourcefiscal 2026$115 million to $120 millionKept
Capital expenditures Sourcefiscal 2026(15) and (10), in millions, as presentedKept
GAAP operating profit Sourcefiscal 2026$141 million to $153 millionKept
Depreciation and amortization Sourcefiscal 202618 and 16, in millions, as presentedKept
Other expense, net Sourcefiscal 2026(1) and (1), in millions, as presentedKept

What changed from last quarter

  • Guidance kept: Management kept the fiscal 2026 guidance introduced in the prior release, with the same net sales, organic growth, EBITDA, EPS and free cash flow ranges. Source

Results and growth drivers

  • Net sales slightly lower: Net sales were $144.2 million, down 1% from $145.2 million a year earlier. Organic sales declined 2% year over year. Source
  • Net earnings and EPS declined: Net earnings were $19.1 million and diluted EPS $0.36, compared with $21.7 million and $0.40 a year earlier. Adjusted diluted EPS was also $0.36. Source
  • Adjusted EBITDA declined to $32.4 million: Adjusted EBITDA was $32.4 million against $34.3 million in the prior-year quarter. Source

Segments and regions

  • IT&S sales fell 3% organically: Industrial Tools & Services organic sales declined 3%, partly offset by 27% growth at Cortland Biomedical. Source
  • IT&S adjusted operating margin narrowed: IT&S adjusted operating profit margin was 25.9% in the quarter, compared with 27.2% in the first quarter of fiscal 2025. Source
  • IT&S adjusted EBITDA margin fell: IT&S adjusted EBITDA margin was 28.2%, from 29.1% in the prior-year first quarter. Source

“We were encouraged by some favorable developments and trends in the quarter for our products, including solid sales growth, particularly in the Americas, and even stronger order growth, reinforcing our cautiously optimistic posture entering 2026.”

Paul Sternlieb, Enerpac Tool Group's President & CEO

Products and customers

  • Product sales up, service sales down: Within IT&S, product sales rose 4% on an organic basis, while service revenue fell 26% year over year. Source
  • Product sales dollars rose: IT&S product net sales were $112.1 million against $106.1 million a year earlier. Service net sales were $25.7 million against $34.0 million. Source
  • Cortland Biomedical sales grew 27%: Cortland Biomedical sales grew 27%, offsetting part of the IT&S decline in the quarter. Source

Demand and order book

  • Order growth described as stronger: Management described order growth as even stronger than the solid sales growth it cited, and tied it to its posture entering 2026. Source
  • Americas sales grew solidly: Management cited solid sales growth, particularly in the Americas, as one of the favorable developments in the quarter for its products. Source
  • UK softness hit service revenue: The service revenue decline was attributed primarily to softness in the UK market. Source

“The Company is maintaining its fiscal 2026 outlook, projecting a net sales range of $635 million to $655 million and organic sales growth of 1% to 4%.”

Enerpac Tool Group Corp., press release

Costs, margins and pricing

  • Adjusted EBITDA margin down 120 basis points: Adjusted EBITDA margin was 22.4%, from 23.6% in the prior-year quarter, on lower gross margin and slight operating expense deleveraging. Source
  • Operating margin 19.8% on both bases: GAAP operating profit was $28.5 million against $31.1 million, and gross profit was $73.2 million against $74.7 million. Source
  • SG&A and amortization rose: Selling, general and administrative expenses were $43.1 million against $42.3 million, and amortization of intangible assets was $1.6 million against $1.2 million. Source

Capital, cash and returns

  • Operating cash generation improved: Cash provided by operating activities was $16.0 million, compared with $8.6 million in the prior-year period. Source
  • Share repurchases returned about $15 million: The company bought about 377,000 shares for $14.9 million in the quarter. Source
  • Net debt 0.3x adjusted EBITDA: Net debt was $49.4 million at November 30, 2025, a ratio of 0.3x to adjusted EBITDA, against 0.5x a year earlier. Source

Investment and balance sheet

  • No acquisition spend this quarter: No cash was paid for business acquisitions in the quarter, against $27.2 million a year earlier. A $0.9 million deferred acquisition payment was made. Source
  • Capital expenditures lower: Capital expenditures were $2.7 million, compared with $5.9 million in the prior-year quarter. Source
  • Cash and debt balances declined: Cash was $139.0 million, down from $151.6 million at August 31, 2025. Debt was $188.5 million, down from $189.7 million. Source

Risks management discussed

  • Demand: Service revenue decline was tied to the UK market. Source
  • Operational: Adjusted EBITDA margin was reduced by lower gross margin and slight operating expense deleveraging on lower sales. Source
  • Regulatory: Guidance assumes no substantial change to the current tariff or regulatory environment. Source
  • External: Guidance is based on the company's key foreign exchange rate assumptions. Source

Earlier plans management reported on

  • Not stated: The company said it is maintaining the fiscal 2026 guidance it introduced in the prior release. Source
  • Not stated: Repurchases in the quarter were made under the program announced in October 2025. Source

Other quarters

Summarised with AI from the documents the company filed with the SEC. Every point is checked against the filing before it is shown: management’s own words word for word, figures against the line or table row they come from. A point that fails the check is left out. Source opens the filing at that line.